New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 28, 2014
05:11 EDTTEVA, TKPYYTeva, Takeda Pharmaceutical agree to commercialize rasagilinein Japan
Teva Pharmaceutical (TEVA) and Takeda Pharmaceutical (TKPYY) have signed an agreement allowing Takeda to commercialize Tevaís innovative treatment for Parkinsonís disease, rasagiline in Japan. Developed by Teva, rasagiline tablets are approved in over 40 countries for the treatment of Parkinsonís disease. Teva developed this product and received its first approval in 2005 in Israel and Europe, and is currently working towards the acquisition of marketing approval of this product in Japan. Under the terms of the agreement, Takeda will develop rasagiline tablets for the Japanese market and submit a New Drug Application for registration of the product in Japan. The financial details of the agreement are confidential.
News For TEVA;TKPYY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 20, 2014
06:28 EDTTEVAAllergan price target raised to $210 from $190 at Citigroup
Subscribe for More Information
October 16, 2014
15:10 EDTTKPYYAmerican College of Gastroenterology to hold annual meeting
ACG Annual Scientific Meeting 2014 to be held in Philadlephia, PA on October 17-22.
October 15, 2014
08:35 EDTTKPYYOrexigen earned $60M milestone payment from Takeda Pharmaceutical
Subscribe for More Information
October 14, 2014
11:23 EDTTEVABIND Therapeutics and The Conference Forum hold a conference
Subscribe for More Information
11:19 EDTTEVATeva upgraded to Buy from Hold at Standpoint Research

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use